Brennan Kiva, McSharry Brian P, Keating Sinéad, Petrasca Andreea, O'Reilly Vincent P, Keane Joseph, Doherty Derek G, Gardiner Clair M
NK Cell Laboratory, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Trinity College, Dublin 2, Ireland.
Department of Immunology, School of Medicine, Trinity College Dublin, Dublin 8, Ireland.
Hum Immunol. 2016 Oct;77(10):876-885. doi: 10.1016/j.humimm.2016.06.018. Epub 2016 Jun 24.
NKG2D is an important activating receptor expressed on NK cells. Ligands (termed NKG2DL) for this receptor include ULBP1-6, MICA and MICB in humans; they are upregulated in stressed, cancerous or infected cells where they engage NKG2D to induce NK cell cytotoxicity and cytokine production. Expression of NKG2DL on effector cells has been described in mice and more recently in human cells. We confirm that NK cell lines and IL-2 stimulated primary human NK cells also express the NKG2DL, ULBP2. However, expression of ULBP2 was not a result of transfer from a non-NK cell to an NK cell and in contrast to recent reports we saw no evidence that ULBP2 expression targeted these NK cells for fratricide or for cytotoxicity by NKG2D-expressing, non-NK effector cells. ULBP2 expression was however linked to expression of mature CD57(+) NK cells. In particular, expression of ULBP2 was strongest on those NK cells that had evidence of recent activation and proliferation. We suggest that ULBP2 could be used to identify recently activated "mature" NK cells. Defining this phenotype would be useful for understanding the ontogeny on human NK cells.
NKG2D是一种在自然杀伤细胞(NK细胞)上表达的重要激活受体。该受体的配体(称为NKG2DL)在人类中包括ULBP1 - 6、MICA和MICB;它们在应激、癌变或受感染的细胞中上调,在这些细胞中它们与NKG2D结合以诱导NK细胞的细胞毒性和细胞因子产生。NKG2DL在效应细胞上的表达已在小鼠中有所描述,最近在人类细胞中也有报道。我们证实NK细胞系和白细胞介素-2刺激的原代人类NK细胞也表达NKG2DL,即ULBP2。然而,ULBP2的表达并非非NK细胞向NK细胞转移的结果,并且与最近的报道相反,我们没有发现证据表明ULBP2的表达会使这些NK细胞成为同胞相残的目标,也不会被表达NKG2D的非NK效应细胞杀伤。然而,ULBP2的表达与成熟CD57(+) NK细胞的表达相关。特别是,ULBP2在那些有近期激活和增殖证据的NK细胞上表达最强。我们认为ULBP2可用于识别近期激活的“成熟”NK细胞。定义这种表型将有助于理解人类NK细胞的个体发生。